Cargando…

Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma

Pancreatic adenocarcinoma (PAAD) has high mortality and a very poor prognosis. Both surgery and chemotherapy have a suboptimal therapeutic effect, and this caused a need to find new approaches such as immunotherapy. Therefore, it is essential to develop a new model to predict patient prognosis and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lei, Mugaanyi, Joseph, Cai, Xingchen, Lu, Caide, Lu, Changjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279485/
https://www.ncbi.nlm.nih.gov/pubmed/35831362
http://dx.doi.org/10.1038/s41598-022-16155-w

Ejemplares similares